Compared to other developed nations, insulin costs in the U.S. are five to ten times higher, setting immense pressures on health insurance systems and patients. As universities provide students with health insurance plans, many educational institutions lose funds yearly for students with diabetes, even with co-pay. As some states enacted legislation to cut these co- […] The post How Big Pharma’s Insulin Price Manipulation Drain Illinois Universities’ Health Insurance Funds appeared first on The Flyer.